2024-03-19 21:59:35 ET
Summary
- The company booked EBITDA of $8.1 million for Q4 FY23 thanks to strong revenue growth at higher margin life sciences and information technology segment.
- However, I’m concerned that FCF and share buybacks were limited by growing accounts receivable and net debt.
- While the company doesn’t look expensive at 8.7X EV/EBITDA, FY24 could be softer than FY23 due to the rising US unemployment rate.
- In my view, this is a good time for investors to trim or close their long positions.
Investment thesis
I've been following RCM Technologies ( RCMT ) closely and I've written three articles about the company on SA. The latest of them was in November 2023 and back then I said that the valuation was starting to look stretched despite my expectations that EBITDA for the FY23 would surpass $20 million....
Read the full article on Seeking Alpha
For further details see:
RCM Technologies: Strong Q4 FY23 Results But FY24 Could Be Challenging